Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly announces the support of the Defeat Diabetes team in the...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy non-profit, joined NBA Miami Heat Assistant Coach and Racine, Wisconsin native...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds the new proposed legislation announced by U.S. Senators...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, together with UMass Chan Medical School announces the appointment...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the launch of the 2022 vehicle sweepstakes for JDRF....
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the appointment of Grant Beard and Michelle Griffin as...
Aspect Biosystems ("Aspect"), a biotechnology company developing bioengineered tissue therapeutics to transform how we treat disease, is pleased to...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces a new collaboration with leading diabetes, advocacy, and ...
The JDRF Illinois One Dream Gala has long been recognized as one of Chicago's top annual philanthropic events, but Saturday night the organization...
JDRF, the leading global funder of type 1 diabetes (T1D) research, is recognizing NFL Stars who are showcasing their passion and creativity to bring...
JDRF, the leading global funder of type 1 diabetes (T1D) research, proudly announces the relaunch of Rufus, the Bear with Diabetes®. The newly...
JDRF, the leading global nonprofit funder of type 1 diabetes (T1D) research, announces a new grant awarded to Albert Einstein College of Medicine and ...
JDRF, the leading global funder of type 1 diabetes research, today proudly announces the inclusion of the book Shia Learns About Insulin into the Bag ...
OneCause, a leader in online and event fundraising, recognized fundraising innovation and excellence at its annual Raise Awards ceremony during the...
JDRF, the leading global funder of type 1 diabetes (T1D) research, proudly announces the appointment of Dr. Shareef Elnahal to the JDRF Research...
JDRF and Beyond Type 1 present the TypeOneNation Summit: Viviendo sin Límites, the first national Spanish-language type 1 diabetes (T1D) community...
JDRF, the leading global organization funding type 1 diabetes (T1D) research, announces, in collaboration with the Harvard Stem Cell Institute, the...
In a world where nonprofits have been hard hit during the pandemic, the JDRF Illinois One Dream Gala-Close to Home set a new global record for the...
On the heels of National Diabetes Awareness Month, JDRF, the leading global funder of type 1 diabetes (T1D) research, has launched a groundbreaking...
Approximately 1 in 5 Americans experience a mental health condition, and the current COVID-19 pandemic has increased demand for mental health...
Michigan Medicine, through its Elizabeth Weiser Caswell Diabetes Institute (EWCDI), and JDRF are collaborating to establish the JDRF Center of...
JDRF, the leading global funder of type 1 diabetes (T1D) research, commemorates National Diabetes Awareness Month (NDAM) by honoring the strength of...
On Saturday, September 26, JDRF, the leading global funder of type 1 diabetes (T1D) research, hosted its first-ever National TypeOneNation Virtual...
JDRF, the leading global organization funding type 1 diabetes (T1D) research, will hold a 12-hour charity fundraiser on Twitch this Saturday, June...
Emily Sims, M.D. today shared new findings that a breakthrough drug significantly delays the onset of type 1 diabetes (T1D). The data presented at...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.